DXRX
vs
F
FTSE All Share Index
DXRX
Over the past 12 months, DXRX has significantly outperformed FTSE All Share Index, delivering a return of +44% compared to the FTSE All Share Index's 0% growth.
Stocks Performance
DXRX vs FTSE All Share Index
Performance Gap
DXRX vs FTSE All Share Index
Performance By Year
DXRX vs FTSE All Share Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Diaceutics PLC
Glance View
Diaceutics Plc engages in the provision of data, data analytics and implementation services. The company is headquartered in Belfast, Northern Ireland. The company went IPO on 2019-03-21. The principal activity of the Company is data analytics and implementation services. The firm is engaged in research and development activities in drug development science, testing data and software platform development. The firm's implementation services include test standardization, test quality assessment, laboratory tech support and others. The firm has established a range of products and outsourced advisory services, which help its pharma clients to optimize and deliver their marketing and implementation strategies for companion diagnostics. The firm provides the pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX - The Diagnostic Network. DXRX is the diagnostic commercialization platform for precision medicine, integrating multiple pipelines of diagnostic testing data from a global network of laboratories.
